We also analysed the ability of the serum NGAL assay to distinguish pancreatic cancer from non-cancer cases by fitting the data to a simple logistic regression model where samples were categorised as ‘cancer’ or ‘no-cancer’, and mean NGAL was used as the predictor. This evidence concerns the gene LCN2 and familial pancreatic carcinoma.